VALIDATION OF ROMANIAN VERSION OF LARS SCORE

  • Octavian Andronic 1The University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania & 2University Emergency Hospital of Bucharest, Romania
  • Gerogiana Radu 1The University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania
  • Dan Nicolae Păduraru 1The University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania & 2University Emergency Hospital of Bucharest, Romania
  • Daniel Ion 1The University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania & 2University Emergency Hospital of Bucharest, Romania
  • Alexandra Bolocan 1The University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania & 2University Emergency Hospital of Bucharest, Romania
  • Sorin Mircea Oprescu 1The University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania & 2University Emergency Hospital of Bucharest, Romania
Keywords: low anterior resection, rectal cancer, LARS score, LARS

Abstract

LARS is a widely spread complication in patients suffering from rectal cancer who had undergone a low anterior resection. Until recently it was very difficult to adequately quantify the impact that this syndrome has on patients’ quality of life. In 2012, a special score was developed and validated in Denmark widely known as the LARS score. Since then, it is on the road to be validated in many countries all around the world. Our study aimed to test its applicability on patients from Romania. The results were conclusive with available literature, thus proving its usefulness and validation in our country

References

[1] Z. Liang, W. Ding, W. Chen, Z. Wang, P. Du, and L. Cui, “Therapeutic Evaluation of Biofeedback Therapy in the Treatment of Anterior Resection Syndrome After Sphincter-Saving Surgery for Rectal Cancer,” Clin. Colorectal Cancer, vol. 15, no. 3, pp. e101–e107, 2016.
[2] F. Bray, J. Ferlay, and I. Soerjomataram, “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” pp. 394–424, 2018.
[3] J. Martellucci, “Low anterior resection syndrome (LARS),” UptoDate, 2019.
[4] K. J. Emmertsen, “Low Anterior Resection Syndrome Score,” 2012.
[5] K. Jøssing, L. Miguel, E. Klaus, and K. Jøssing, “International validation of the low anterior resection syndrome score International Validation of the Low Anterior Resection Syndrome Score,” vol. 259, pp. 728–734, 2014.
[6] P. M. Kasi, F. Shahjehan, J. J. Cochuyt, Z. Li, D. T. Colibaseanu, and A. Merchea, “Rising Proportion of Young Individuals with Rectal and Colon Cancer,” Clin. Colorectal Cancer, vol. 18, no. 1, pp. e87–e95, 2019.
[7] X. Hou et al., “Validation of the Chinese version of the low anterior resection syndrome score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients,” Eur. J. Oncol. Nurs., vol. 19, no. 5, pp. 495–501, 2015.
[8] A. Carrillo et al., “Incidence and Characterization of the Anterior Resection Syndrome Through the Use of the LARS Scale (Low Anterior Resection Score),” Cirugía Española (English Ed., vol. 94, no. 3, pp. 137–143, 2016.
[9] A. Sturiale et al., “Long-term functional follow-up after anterior rectal resection for cancer,” Int. J. Colorectal Dis., vol. 32, no. 1, pp. 83–88, Jan. 2017.
[10] N. E. Samalavicius, A. Dulskas, M. Lasinskas, and G. Smailyte, “Validity and reliability of a Lithuanian version of low anterior resection syndrome score,” Tech. Coloproctol., 2016.
[11] P. Ekkarat, T. Boonpipattanapong, K. Tantiphlachiva, and S. Sangkhathat, “Factors determining low anterior resection syndrome after rectal cancer resection: A study in Thai patients,” Asian J. Surg., vol. 39, no. 4, pp. 225–231, 2016.
[12] D. L. Hughes, J. Cornish, and C. Morris, “Functional outcome following rectal surgery—predisposing factors for low anterior resection syndrome,” Int. J. Colorectal Dis., vol. 32, no. 5, pp. 691–697, May 2017.
[13] L. M. Jimenez-Gomez, E. Espin-Basany, M. Marti-Gallostra, J. L. Sanchez-Garcia, F. Vallribera-Valls, and M. Armengol-Carrasco, “Low anterior resection syndrome: a survey of the members of the American Society of Colon and Rectal Surgeons (ASCRS), the Spanish Association of Surgeons (AEC), and the Spanish Society of Coloproctology (AECP),” Int. J. Colorectal Dis., 2016.
[14] L. Trenti et al., “Quality of life and anterior resection syndrome after surgery for mid to low rectal cancer: A cross-sectional study,” Eur. J. Surg. Oncol., vol. 44, no. 7, pp. 1031–1039, Jul. 2018.
[15] N. J. Rama, P. L. Ferreira, J. Pimentel, and T. Juul, “Validation of Portuguese version of the low anterior resection syndrome score,” J. Coloproctology, vol. 39, no. 1, pp. 1–8, Jan. 2019.
[16] A. D. Croese, J. M. Lonie, A. F. Trollope, V. N. Vangaveti, and Y.-H. Ho, “A meta-analysis of the prevalence of Low Anterior Resection Syndrome and systematic review of risk factors,” Int. J. Surg., vol. 56, pp. 234–241, Aug. 2018.
[17] A. M. Couwenberg et al., “Effect of Neoadjuvant Therapy and Rectal Surgery on Health-related Quality of Life in Patients with Rectal Cancer During the First 2 Years After Diagnosis,” Clin. Colorectal Cancer, vol. 17, no. 3, pp. e499–e512, 2018.
Published
2020-01-24
How to Cite
[1]
O. Andronic, G. Radu, D. N. Păduraru, D. Ion, A. Bolocan, and S. M. Oprescu, “VALIDATION OF ROMANIAN VERSION OF LARS SCORE”, JSS, vol. 7, no. 1, pp. 154-159, Jan. 2020.
Section
Articles